Browse Categories
Search
Stay In Touch
Login
|
|
Home > All Products > CBI's 8th Annual Pharmaceutical Compliance Congress - Online Compendium
CBI's 8th Annual Pharmaceutical Compliance Congress - Online Compendium
|
Item Number: C11Q001
The premier life sciences compliance forum led by industry compliance professionals
-
Key insights and lessons learned operating under a Corporate Integrity Agreement
-
Trends in enforcement -- areas of focus for state and federal prosecutors
-
The building blocks of an effective compliance program
-
Best practices in compliance monitoring and investigations
-
Effective training strategies and tools to communicate compliance across the business
-
Analysis of PPACA -- the implications of healthcare reform on compliance teams
-
Adhering to global anti-corruption statutes
-
How multi-national companies can tailor existing U.S. practices to build a global compliance program
-
U.S. and foreign compliance and enforcement issues related to clinical research
-
How come the business never detected this before?
-
The "8th Element" of an effective compliance and ethics program -- the risk assessment
-
Implications of regulatory and policy changes on government pricing
-
Areas that raise compliance and legal concerns regarding relationships with institutional providers
-
Examining solutions for managing off-label compliance
-
Best practices in monitoring field-based personnel for off-label promotion
|
|
|
|